+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urological Disorders Drugs Market Research Reports

Global Urinary Tract Infections Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Urinary Tract Infections Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Overactive Bladder Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Overactive Bladder Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Urinary Incontinence Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Urinary Incontinence Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Overactive Bladder Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Overactive Bladder Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Germany Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030 - Product Thumbnail Image

Germany Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030

  • Report
  • March 2023
  • 15 Pages
  • Germany
From
Canada Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030 - Product Thumbnail Image

Canada Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030

  • Report
  • March 2023
  • 15 Pages
  • Canada
From
Australia Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030 - Product Thumbnail Image

Australia Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030

  • Report
  • March 2023
  • 15 Pages
  • Australia
From
India Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030 - Product Thumbnail Image

India Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030

  • Report
  • March 2023
  • 15 Pages
  • India
From
Urinary Incontinence Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Urinary Incontinence Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • August 2022
  • 376 Pages
  • Global
From
Ascorbic Acid Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region - Product Thumbnail Image

Ascorbic Acid Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region

  • Report
  • February 2024
  • 217 Pages
  • Global
Urinary Incontinence Market Report with COVID Impact - Global - 2022 - 2028 - MedCore - Product Thumbnail Image

Urinary Incontinence Market Report with COVID Impact - Global - 2022 - 2028 - MedCore

  • Report
  • June 2022
  • 65 Pages
  • Global
From
Rocephin - API Insight, 2022 - Product Thumbnail Image

Rocephin - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Zosyn - API Insight, 2022 - Product Thumbnail Image

Zosyn - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Toviaz - API Insight, 2022 - Product Thumbnail Image

Toviaz - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Invanz - API Insight, 2022 - Product Thumbnail Image

Invanz - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Zerbaxa - API Insight, 2022 - Product Thumbnail Image

Zerbaxa - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Unasyn - API Insight, 2022 - Product Thumbnail Image

Unasyn - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Hyoscyamine Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hyoscyamine Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • March 2025
  • 73 Pages
  • Global
From
Desmopressin (DDAVP) Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Desmopressin (DDAVP) Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • March 2025
  • 96 Pages
  • Global
From
Imipramine Hydrochloride Tablet Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Imipramine Hydrochloride Tablet Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • March 2025
  • 74 Pages
  • Global
From
Loading Indicator

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them. Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more